Navigation Links
Accumedic Electronic Medical Record Software Interface / Patient Demographics

ProductsAccumedic Electronic Medical Record Software Interface / Patient Demographics
Company Accumedic Computer Systems, Inc.
Item Accumedic Electronic Medical Record Software Interface / Patient Demographics
Features 
  • Patient recall
  • Sliding scale
  • Alerts
  • Scanner and digital camera support
  • Tracks and processes multiple insurance policies
  • Records usual therapists, referring providers and office locations
  • User-definable notes
Description Accumedics Electronic Medical Record Software Interface enables real-time HL7 EDI Interface with programs, populates patient demographics, and provides custom reports. Accumedics Electronic Medical Record Software Interface is Microsoft compatible allowing data migration into your office and email systems.
Info Accumedic Computer Systems, Inc.
Customer Service: (800) 765-9300
Web site: http://www.accumedic.com/

Related medicine products :

1. MaximEyes Practice Management and Electronic Medical Records Software Solutions
2. PRAXIS® Electronic Medical Records v. 2.19
3. MaximEyes Optometric & Ophthalmology Software for Practice Management and Electronic Medical Records
4. ExamWRITER Electronic Medical Records
5. NextGen Electronic Medical Records module
6. PrimeSuite Integrated Practice Management, Electronic Medical Record (EMR) and Managed Care solutions
7. Cardiology Software for Electronic Medical Records
8. HealthMatics EMR Electronic Medical Record
9. Littmann Electronic Stethoscope Model 2000
10. 3M Littmann Electronic Stethoscope Model 4100WS with Ambient Noise Reduction
11. Eppendorf EDOS Electronic Dispensing System
Breaking Medicine Technology:GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 2GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 3GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 4GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 5GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 6Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4New Executive Leadership and CEO Announced for BiPar Sciences 2Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost 12946 1Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost 12946 2Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost 12946 3Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost 12946 4Research shows that invisible hand guides evolution of cooperative turn taking 9182 1Research shows that invisible hand guides evolution of cooperative turn taking 9182 2Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis 4702 1Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis 4702 2